Ages 1–7 years · First-line protocol

Treatment of Retropharyngeal Abscess in Children Aged 1–7 Years (Non-Toxic, Hemodynamically Stable)

This protocol addresses the inpatient management of retropharyngeal, parapharyngeal, or pharyngeal abscess in children older than 12 months and younger than 7 years who present in a non-toxic state and are hemodynamically stable.

Clinical Scenario

The patient is a child aged over 12 months and under 7 years presenting with retropharyngeal, parapharyngeal, or pharyngeal abscess. Key qualifying features include:

• Non-toxic appearance
• Able to handle secretions
• Hemodynamically stable
• No penicillin allergy; no history of MRSA
• Not immunocompromised; no prior neck or airway surgery
• No signs of sepsis, shock, airway compromise, or head/neck/airway trauma

Treatment Approach

Management begins with admission to inpatient pediatric care and initiation of IV antibiotic therapy, alongside pain management, IV fluid support, and diet as tolerated. Once the patient demonstrates clinical improvement, the protocol outlines a step-down to oral antibiotics to complete the treatment course.

Clinical Goals

Success is defined by a well-appearing child with stable vital signs, an improving fever curve and laboratory findings, and the ability to tolerate oral medication and diet — typically within 24–48 hours of beginning antibiotic treatment.